RN
$6.45
-0.30
(-4.44%)
As of May 26, 2026, 8:52 PM EDT
Cartesian Therapeutics Inc (RNAC) is trading down at $6.45 (-4.44%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Recent News (2)
-
Cartesian Therapeutics stock price target maintained at $40 by Mizuho
Cartesian Therapeutics stock price target maintained at $40 by Mizuho
-
SpaceX Is A 'Money Furnace,' Former Hedge Fund Manager Says As Filing Reveals $4.3 Billion Quarterly Loss SpaceX Is A 'Money Furnace,' Former Hedge Fund Manager Says As Filing Reveals $4.3 Billion Quarterly Loss